275 related articles for article (PubMed ID: 31806967)
1. In Situ Forming Injectable Hydrogel For Encapsulation Of Nanoiguratimod And Sustained Release Of Therapeutics.
Ma Z; Tao C; Sun L; Qi S; Le Y; Wang J; Li C; Liu X; Zhang J; Zhao J
Int J Nanomedicine; 2019; 14():8725-8738. PubMed ID: 31806967
[TBL] [Abstract][Full Text] [Related]
2. Iguratimod ameliorates rheumatoid arthritis progression through regulating miR-146a mediated IRAK1 expression and TRAF6/JNK1 pathway: an in vivo and in vitro study.
Kong R; Gao J; Ji L; Peng Y; Zhang J; Zhao D
Clin Exp Rheumatol; 2021; 39(2):289-303. PubMed ID: 32662411
[TBL] [Abstract][Full Text] [Related]
3. Highly Efficient Oral Iguratimod/Polyvinyl Alcohol Nanodrugs Fabricated by High-Gravity Nanoprecipitation Technique for Treatment of Rheumatoid Arthritis.
Tao C; Li F; Ma Z; Li X; Zhang Y; Le Y; Wang J; Zhao J; Liu C; Zhang J
Small; 2024 Mar; 20(13):e2304150. PubMed ID: 37964398
[TBL] [Abstract][Full Text] [Related]
4. In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer.
Lo YW; Sheu MT; Chiang WH; Chiu YL; Tu CM; Wang WY; Wu MH; Wang YC; Lu M; Ho HO
Acta Biomater; 2019 Mar; 86():280-290. PubMed ID: 30616077
[TBL] [Abstract][Full Text] [Related]
5. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate.
Tekko IA; Chen G; Domínguez-Robles J; Thakur RRS; Hamdan IMN; Vora L; Larrañeta E; McElnay JC; McCarthy HO; Rooney M; Donnelly RF
Int J Pharm; 2020 Aug; 586():119580. PubMed ID: 32593650
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-35 (IL-35) inhibits proliferation and promotes apoptosis of fibroblast-like synoviocytes isolated from mice with collagen-induced arthritis.
Li Y; Wu S; Li Y; Jiang S; Lin T; Xia L; Shen H; Lu J
Mol Biol Rep; 2016 Sep; 43(9):947-56. PubMed ID: 27379996
[TBL] [Abstract][Full Text] [Related]
7. Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes.
Lin J; Yu Y; Wang X; Ke Y; Sun C; Yue L; Xu G; Xu B; Xu L; Cao H; Xu D; Olsen N; Chen W
J Immunol Res; 2019; 2019():6929286. PubMed ID: 31828173
[TBL] [Abstract][Full Text] [Related]
8. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
[TBL] [Abstract][Full Text] [Related]
9. A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide.
Luo Q; Sun Y; Liu W; Qian C; Jin B; Tao F; Gu Y; Wu X; Shen Y; Xu Q
J Immunol; 2013 Nov; 191(10):4969-78. PubMed ID: 24123677
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid thiol modified injectable hydrogel: Synthesis, characterization, drug release, cellular drug uptake and anticancer activity.
Xu K; Yao H; Fan D; Zhou L; Wei S
Carbohydr Polym; 2021 Feb; 254():117286. PubMed ID: 33357859
[TBL] [Abstract][Full Text] [Related]
11. Intra-articular Retention and Anti-arthritic Effects in Collagen-Induced Arthritis Model Mice by Injectable Small Interfering RNA Containing Hydrogel.
Kanazawa T; Tamano K; Sogabe K; Endo T; Ibaraki H; Takashima Y; Seta Y
Biol Pharm Bull; 2017; 40(11):1929-1933. PubMed ID: 29093340
[TBL] [Abstract][Full Text] [Related]
12. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate Aspasomes Against Rheumatoid Arthritis: Optimized Hydrogel Loaded Liposomal Formulation with In Vivo Evaluation in Wistar Rats.
Ghosh S; Mukherjee B; Chaudhuri S; Roy T; Mukherjee A; Sengupta S
AAPS PharmSciTech; 2018 Apr; 19(3):1320-1336. PubMed ID: 29340978
[TBL] [Abstract][Full Text] [Related]
14. Triptolide decreases rheumatoid arthritis fibroblast-like synoviocyte proliferation, invasion, inflammation and presents a therapeutic effect in collagen-induced arthritis rats via inactivating lncRNA RP11-83J16.1 mediated URI1 and β-catenin signaling.
Piao X; Zhou J; Xue L
Int Immunopharmacol; 2021 Oct; 99():108010. PubMed ID: 34358861
[TBL] [Abstract][Full Text] [Related]
15. Exploring and characterizing a novel combination of paeoniflorin and talatizidine for the treatment of rheumatoid arthritis.
Mao X; Li W; Chen W; Li Y; Wang Q; Wang X; Pi Z; Wang D; Xu H; Guo Q; Wu S; Cheng W; Zhang Y; Lin N
Pharmacol Res; 2020 Mar; 153():104658. PubMed ID: 32001347
[TBL] [Abstract][Full Text] [Related]
16. Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1β-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Wang XT; Li P; Xu TS; Ding R; Zhang X; Bi LQ
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):44-50. PubMed ID: 27894399
[TBL] [Abstract][Full Text] [Related]
17. A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients.
Ma JD; Jing J; Wang JW; Yan T; Li QH; Mo YQ; Zheng DH; Gao JL; Nguyen KA; Dai L
Arthritis Res Ther; 2019 Jun; 21(1):153. PubMed ID: 31234900
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine for the Treatment of Rheumatoid Arthritis.
Jeong M; Park JH
Mol Pharm; 2021 Feb; 18(2):539-549. PubMed ID: 32502346
[TBL] [Abstract][Full Text] [Related]
19. Iguratimod in combination with methotrexate in active rheumatoid arthritis : Therapeutic effects.
Xia Z; Lyu J; Hou N; Song L; Li X; Liu H
Z Rheumatol; 2016 Oct; 75(8):828-833. PubMed ID: 26508503
[TBL] [Abstract][Full Text] [Related]
20. Nano polydopamine crosslinked thiol-functionalized hyaluronic acid hydrogel for angiogenic drug delivery.
Yegappan R; Selvaprithiviraj V; Mohandas A; Jayakumar R
Colloids Surf B Biointerfaces; 2019 May; 177():41-49. PubMed ID: 30711759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
